Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
MMWR. Morbidity and Mortality Weekly Report|February 15, 2019
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019Joshua D Doyle, Jessie R Chung, Sara S Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 seasonJessie R Chung, Ashley M Price, Richard K Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2025
Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 seasonJessie R Chung, Ashley M Price, Richard K Zimmerman, et al.
The Journal of Infectious Diseases|October 31, 2019
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 SeasonBrendan Flannery, Rebecca J Garten Kondor, Jessie R Chung, et al.
Plos Pathogens|March 25, 2026
The impact of viral and host factors on the influenza A virus transmission bottleneckKathryn C Krupinsky, Emily E Bendall, Yuwei Zhu, et al.
Influenza and Other Respiratory Viruses|June 26, 2024
Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023Jessie R Chung, Philip Shirk, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|February 21, 2020
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020Fatimah S Dawood, Jessie R Chung, Sara S Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysisZoe Raglow, Diya Surie, James D Chappell, et al.
The Lancet. Microbe|January 29, 2024
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysisZoe Raglow, Diya Surie, James D Chappell, et al.
Pageof 27